ERS International Congress, Madrid, 2019: highlights from the Paediatric Assembly

Raffaella Nenna1, Monique Slaats2, Refika Ersu3

  • 1Maternal-Infantile and Urological Science Dept, "Sapienza" University of Rome, Rome, Italy.

ERJ Open Research
|July 28, 2020
PubMed

Insights

This review summarizes key paediatric respiratory research from the 2019 European Respiratory Society (ERS) International Congress. It covers significant advancements and findings in paediatric pulmonology presented by experts.

Area of Science:

  • Pediatric Respiratory Medicine
  • Pulmonology
  • Clinical Pediatrics

Background:

  • The European Respiratory Society (ERS) Paediatric Assembly convenes experts in pediatric respiratory health.
  • The 2019 ERS International Congress showcased cutting-edge research in the field.
  • Early career members and group chairs provide a curated overview of presented findings.

Purpose of the Study:

  • To highlight significant and interesting findings in pediatric respiratory medicine from the 2019 ERS International Congress.
  • To provide a concise summary of key advancements presented in Madrid.
  • To offer insights from both established and emerging researchers in the field.

Main Methods:

  • Review and synthesis of presentations from the 2019 ERS International Congress.
  • Expert commentary and summarization by Group Chairs and Early Career Members of the Paediatric Assembly.
  • Organization of findings by topic, with summaries at the end of each chapter.

Main Results:

  • Identification of several key findings across various pediatric respiratory subspecialties.
  • Summaries of novel research in areas such as asthma, cystic fibrosis, and congenital lung disease.
  • Insights into the latest diagnostic and therapeutic developments in pediatric pulmonology.

Conclusions:

  • The 2019 ERS Congress presented impactful research advancing pediatric respiratory care.
  • This article serves as a valuable resource for clinicians and researchers seeking an overview of recent pediatric pulmonology advancements.
  • Continued innovation in the field promises improved outcomes for children with respiratory conditions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
148
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
176
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K